CRISAL Study:Cancer Risk In Secreting Adrenal Lesions

Recruiting now

Conditions studied: Adrenal Tumor, Adrenal Incidentaloma, Surgery

In brief

The aim of the present study is to report the cancer risk in secreting adrenal lesions. Secondary aims: to compare the incidence of cancer in secreting versus non-secreting adrenal lesions, in order to evaluate whether adrenal hormone activity can be considered an independent predictive indicator of malignancy; compare intraoperative and 30-day postoperative outcomes of patients undergoing adrenalectomy for secreting adrenal lesions versus non-secretoring lesions; regardless of the type of adrenal lesion, identify if there is one MIS adrenal approach that is superior to the others in terms of intra- and postoperative outcomes.

Key facts

Study ID

NCT06520111

Run by

University of Roma La Sapienza

People needed

300

Starts

2024-08-27

Expected to finish

2024-11-10

Last updated by the study team

2024-08-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing elective adrenalectomy;
• Patients aged ≥ 18 years
• Acceptance of informed consent

You may not qualify if…

• Patients undergoing emergency adrenalectomy;
• Patients aged ≤ 18 years
• Pregnant patients

Where it is running

• General and Mininvasive Surgery Department, Pederzoli Hospital, — Peschiera del Garda, Verona, Italy., Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.